StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
RaQualia Pharma Inc.
Tokyo Stock Exchange:4579.T
Sector
Location
Market Cap
USD 89.08 M
Share Price
USD 3.65
Avg Daily Volume
298,219
Change (1 day)
0.50%
Change (1 year)
0.02%
Change (YTD)
49.04%
RaQualia Pharma Inc. Current Assets for the year ending December 31, 2024: USD 28.87 M
RaQualia Pharma Inc. Current Assets is USD 28.87 M for the year ending December 31, 2024, a -17.82% change year over year. Current assets are assets that are expected to be converted into cash or used within one year.
-
RaQualia Pharma Inc. Current Assets for the year ending December 31, 2023 was USD 35.13 M, a -4.44% change year over year.
-
RaQualia Pharma Inc. Current Assets for the year ending December 31, 2022 was USD 36.76 M, a 5.71% change year over year.
-
RaQualia Pharma Inc. Current Assets for the year ending December 31, 2021 was USD 34.78 M, a 26.80% change year over year.
-
RaQualia Pharma Inc. Current Assets for the year ending December 31, 2020 was USD 27.43 M, a -2.80% change year over year.
Competitors
Sumitomo Pharma Co., Ltd.
USD 6.19
4506.T
+0.05
0.87%
Guobang Pharma Ltd.
USD 2.84
605507.SS
+0.01
0.33%
Eli Lilly and Company
USD 780.67
LLY
+1.39
0.18%
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Novo Nordisk A/S
USD 71.08
NOVO-B.CO
+2.24
3.26%
Roche Holding AG
USD 347.79
RO.SW
+3.30
0.96%
Novartis AG
USD 123.46
NOVN.SW
+2.11
1.74%
Abbott Laboratories
USD 134.44
ABT
+0.33
0.25%
AstraZeneca PLC
USD 140.96
AZN.L
+1.64
1.18%
Merck & Co., Inc.
USD 80.93
MRK
-1.46
-1.77%
Amgen Inc.
USD 298.24
AMGN
+1.39
0.47%
Pfizer Inc.
USD 25.38
PFE
+0.06
0.24%
Gilead Sciences, Inc.
USD 111.75
GILD
+0.24
0.21%
Sanofi
USD 98.03
SAN.PA
+1.08
1.11%
Vertex Pharmaceuticals Incorporated
USD 459.62
VRTX
+2.59
0.57%
Bristol-Myers Squibb Company
USD 46.92
BMY
-0.71
-1.49%
Chugai Pharmaceutical Co., Ltd.
USD 49.30
4519.T
+0.76
1.57%
CSL Limited
USD 158.90
CSL.AX
+0.55
0.35%
GSK plc
USD 19.16
GSK.L
+0.13
0.68%
Zoetis Inc.
USD 159.18
ZTS
+0.10
0.06%
Key Data
| Date | Current Assets | Property, Plant, Equipment (Net) | Total Assets | Accounts Payable |
|---|
Competitors
Sumitomo Pharma Co., Ltd.
USD 6.19
4506.T
+0.05
0.87%
Guobang Pharma Ltd.
USD 2.84
605507.SS
+0.01
0.33%
Eli Lilly and Company
USD 780.67
LLY
+1.39
0.18%
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Novo Nordisk A/S
USD 71.08
NOVO-B.CO
+2.24
3.26%
Roche Holding AG
USD 347.79
RO.SW
+3.30
0.96%
Novartis AG
USD 123.46
NOVN.SW
+2.11
1.74%
Abbott Laboratories
USD 134.44
ABT
+0.33
0.25%
AstraZeneca PLC
USD 140.96
AZN.L
+1.64
1.18%
Merck & Co., Inc.
USD 80.93
MRK
-1.46
-1.77%
Amgen Inc.
USD 298.24
AMGN
+1.39
0.47%
Pfizer Inc.
USD 25.38
PFE
+0.06
0.24%
Gilead Sciences, Inc.
USD 111.75
GILD
+0.24
0.21%
Sanofi
USD 98.03
SAN.PA
+1.08
1.11%
Vertex Pharmaceuticals Incorporated
USD 459.62
VRTX
+2.59
0.57%
Bristol-Myers Squibb Company
USD 46.92
BMY
-0.71
-1.49%
Chugai Pharmaceutical Co., Ltd.
USD 49.30
4519.T
+0.76
1.57%
CSL Limited
USD 158.90
CSL.AX
+0.55
0.35%
GSK plc
USD 19.16
GSK.L
+0.13
0.68%
Zoetis Inc.
USD 159.18
ZTS
+0.10
0.06%